BiomX (PHGE) Total Current Liabilities (2018 - 2026)
BiomX's (PHGE) quarterly Total Current Liabilities came in at $10.2 million in Q2 2026, up 62.57% year-over-year from $6.3 million in Q2 2025, and up 316.02% quarter-over-quarter from $2.4 million in Q1 2026.
Analysis
BiomX (PHGE) Total Current Liabilities (2018 - 2026) Analysis & Trends
BiomX has disclosed Total Current Liabilities across 9 years of filings, most recently posting $10.2 million for Q2 2026.
- In Q2 2026, Total Current Liabilities rose 62.57% year-over-year to $10.2 million; the TTM figure through Jun 2026 stood at $10.2 million (up 62.57% YoY), while the FY2025 annual figure was $6.4 million, down 22.84% from the prior year.
- Total Current Liabilities came in at $10.2 million for Q2 2026 at BiomX, up from $2.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $12.8 million in Q3 2023 to a low of $2.4 million in Q1 2026.
- Average Total Current Liabilities over 5 years is $8.2 million, with a median of $7.9 million recorded in 2022.
- Year-over-year, Total Current Liabilities soared 79.77% in 2023 and slumped 65.15% in 2026.
- Over 5 years, Total Current Liabilities stood at $7.9 million in 2022, then surged by 40.77% to $11.2 million in 2023, then slipped by 26.03% to $8.3 million in 2024, then decreased by 22.84% to $6.4 million in 2025, then soared by 59.59% to $10.2 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $10.2 million in Q2 2026, $2.4 million in Q1 2026, and $6.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 25.50 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 11.02 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 3.94 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 5.53 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 1.58 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 2.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 3.92 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 438.74 Mn |
| 10 | BiomX | 1.55 Mn | 7.73 Mn | 97,000.00 | 10.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.18 Mn |
| Mar 31, 2026 | 2.45 Mn |
| Dec 31, 2025 | 6.38 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Jun 30, 2025 | 6.26 Mn |
| Mar 31, 2025 | 7.02 Mn |
| Dec 31, 2024 | 8.27 Mn |
| Sep 30, 2024 | 8.94 Mn |
| Jun 30, 2024 | 7.31 Mn |
| Dec 31, 2023 | 11.18 Mn |
| Sep 30, 2023 | 12.78 Mn |
| Jun 30, 2023 | 11.67 Mn |
| Mar 31, 2023 | 10.20 Mn |
| Dec 31, 2022 | 7.94 Mn |
| Sep 30, 2022 | 7.48 Mn |
| Jun 30, 2022 | 6.49 Mn |
| Mar 31, 2022 | 9.85 Mn |
| Dec 31, 2021 | 11.04 Mn |
| Sep 30, 2021 | 9.00 Mn |
| Jun 30, 2021 | 7.76 Mn |